Evaluating niraparib versus active symptom control in patients with previously treated mesothelioma (NERO): a study protocol for a multicentre, randomised, two-arm, open-label phase II trial in UK secondary care centres.

Dean FennellDaniel GriffithsZina EmintonAbigail Morgan-FoxKayleigh HillSean EwingsCharlotte StuartLucy JohnsonKim MallardMavis NyeLiz DarlisonSean DullooJudith CaveJin-Li LuoPaul TaylorJake B SpicerCharlotte PoileAleksandra BzuraGareth Griffiths

Published in: BMJ open (2023)

ISCRTN16171129; NCT05455424.

Keyphrases

open label
clinical trial
study protocol
phase ii
phase iii
phase ii study
healthcare
cross sectional
palliative care
double blind
quality improvement
randomized controlled trial
placebo controlled
affordable care act
pain management
patient reported
health insurance
locally advanced